To understand the regulation and effect of VEGFR3 in the different BC cell lines upon doxorubicin treatment, we performed a comprehensive analysis of the mRNA expression using real-time quantitative PCR (RT-qPCR). The gene discussed is FLT4; the disease is breast cancer.